Literature DB >> 7679246

Liver damage in patients with colony-stimulating factor-producing tumors.

A Suzuki1, T Takahashi, Y Okuno, S Seko, Y Fukuda, K Nakamura, M Fukumoto, Y Konaka, H Imura.   

Abstract

PURPOSE: We have demonstrated that colony-stimulating factor (CSF)-producing tumor cell lines produce not only CSF but also interleukin-1 (IL-1) and interleukin-6 (IL-6). Clinically, we have observed that patients bearing such tumors present with liver dysfunction and fever in addition to marked leukocytosis. The purpose of this study was to determine whether or not the liver damage was specifically related to CSF-producing tumors. PATIENTS AND METHODS: Clinicopathologic examinations were performed in six autopsied patients with CSF-producing tumors. We also transplanted two tumor cell lines (KHC287 and CHU-2), which produce granulocyte (G)-CSF, IL-1, and IL-6, to nude mice.
RESULTS: Of the six patients, five had G-CSF- and one had granulocyte/macrophage (GM)-CSF-producing tumors. IL-1 and IL-6 concentrations in plasma or culture supernatant were elevated in these patients. Biochemical examinations revealed high serum enzyme levels of the biliary system in contrast to normal or slight increases in transaminase levels in all patients studied. Serum direct bilirubin was elevated in five of the six patients. Three common pathologic changes of the liver were found: (1) focal necrosis associated with neutrophil infiltration in the centrilobular zones, (2) fibrous change and enlargement of the portal area associated with neutrophil infiltration, and (3) intrahepatic cholestasis. The same pathologic changes, except for cholestasis, were reproduced in the liver of mice transplanted with KHC287 or CHU-2.
CONCLUSION: These results indicate that patients with CSF-producing tumors have characteristic liver damage, and suggest a new paraneoplastic syndrome of leukocytosis and liver damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679246     DOI: 10.1016/0002-9343(93)90173-m

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Ki-1 lymphoma with nodular involvement in liver and spleen: possible role of cytokines in systemic manifestation of fever and leukocytosis.

Authors:  Y Harada; S Yamada; S Murakami; S Mine; Y Momosaka; J Tsukada; I Morimoto; S Eto
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Administration of granulocyte colony stimulating factor after liver transplantation leads to an increased incidence and severity of ischemic biliary lesions in the rat model.

Authors:  Olaf Dirsch; Haidong Chi; Yuan Ji; Yan Li Gu; Christoph E Broelsch; Uta Dahmen
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

3.  Granulocyte colony-stimulating factor-producing squamous cell carcinoma of the tongue exhibiting characteristic fluorine-18 deoxyglucose accumulation on positron emission tomography-computed tomography: A case report.

Authors:  Hiroaki Shimamoto; Yuka Hirota; Yoshihisa Kashima; Naoya Kinoshita; Misaki Yokokawa; Tohru Ikeda; Hiroyuki Harada
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

4.  Esophageal Carcinosarcoma that Was Diagnosed as a Granulocyte-colony Stimulating Factor and Interleukin-6-producing Tumor with a Tumor Fever.

Authors:  Taro Shioga; Shozo Matsushima; Eiji Yamada; Takashi Uchiyama; Haruka Noto; Daisuke Suzuki; Takashi Nonaka; Shiro Miyazawa; Tatsuji Komatsu; Yuji Yamamoto; Hitoshi Sekido; Hitoshi Niino
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

Review 5.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

6.  Stimulating More Than Just the Granulocytes: Drug-Induced Liver Injury From Filgrastim.

Authors:  Disha Sharma; Ben L Da; Anusha Vittal; Devika Kapuria; Theo Heller; Gil Ben Yakov
Journal:  ACG Case Rep J       Date:  2019-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.